Novo Nordisk (NVO)
$40.00 +2.20% Close Oct 30, 2026 Live
Novo Nordisk stock today
Novo Nordisk closed at $40.00 on October 30, 2026, up 2.20% on the day. Over the past year it returned -16.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $178 billion.
$40.00$50.00$60.00
NovJan 2026MarMayJulSep
| Period | NVO | S&P 500 (SPY) |
|---|---|---|
| 1 month | +5.5% | -0.9% |
| 3 months | -21.5% | +2.1% |
| Year to date | -17.6% | +11.7% |
| 1 year | -16.2% | +12.4% |
| 3 years | -54.9% | +88.5% |
| 5 years | -18.8% | +76.0% |
Key statistics
- Market value
- $178B
- P/E (trailing)
- 9.9
- Price / sales
- 3.5
- Dividend yield
- 4.49%
- 52-week range
- $35.29 to $63.98
- Next report
- Nov 4, 2026
About Novo Nordisk
Manufactures and sells diabetes, obesity, and cardiovascular pharmaceuticals.
Sector: Health Care · Industry: Pharmaceuticals
More on Novo Nordisk
- Financials: revenue, earnings and segmentsRevenue +20% in the year to Dec 2025
- Valuation: P/E history and peersP/E 9.9, median 24.3 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $2,774 today
No forecast, no recommendation. This page describes Novo Nordisk from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.